Cargando…
Obesity-induced pancreatopathy in rats is reversible after bariatric surgery
Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, to analyze effects of bariatric surgery. Sixty-three male Wistar rats were included in five...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214994/ https://www.ncbi.nlm.nih.gov/pubmed/30390093 http://dx.doi.org/10.1038/s41598-018-34515-3 |
_version_ | 1783368054329049088 |
---|---|
author | Rebours, Vinciane Garteiser, Philippe Ribeiro-Parenti, Lara Cavin, Jean-Baptiste Doblas, Sabrina Pagé, Gwenaël Bado, André Couvineau, Alain Ruszniewski, Philippe Paradis, Valérie Le Gall, Maude Van Beers, Bernard E. Couvelard, Anne |
author_facet | Rebours, Vinciane Garteiser, Philippe Ribeiro-Parenti, Lara Cavin, Jean-Baptiste Doblas, Sabrina Pagé, Gwenaël Bado, André Couvineau, Alain Ruszniewski, Philippe Paradis, Valérie Le Gall, Maude Van Beers, Bernard E. Couvelard, Anne |
author_sort | Rebours, Vinciane |
collection | PubMed |
description | Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, to analyze effects of bariatric surgery. Sixty-three male Wistar rats were included in five groups: 2 fed with high fat diet (HFD) or normal diet for 3 months, 2 fed with HFD or normal diet for 6 months; 1 group fed with HFD and undergoing bariatric surgery (n = 30). Quantitative MR imaging was performed in HFD(6), ND(6) and HFD(3)-BS. Pancreas specimens were analyzed after sacrifice for adipocyte infiltration, fibrosis, acinar-ductal metaplasia, abnormality of Langerhans islets (HHF: hypertrophy, hypervascularisation, fibrosis), and hemosiderin deposits in acinar or endocrine locations. We found that HFD(6) rats had more fibro-inflammatory islets (P = 0.0139) and acinar-ducal metaplasia (P = 0.0843) than HFD(3) rats. Rats with HFD(3+6) had more fibro-inflammatory islets (P < 0.0001), hemosiderin deposits (p < 0.0001), fat infiltration (P = 0.0008) and acinar-ductal metaplasia lesions (P = 0.0424). Weight increase was associated with glycoregulation abnormalities (r = 0.44, P = 0.08) and adipocyte infiltrations (P = 0.009). After surgery, less fibro-inflammatory islets (P = 0.0004), fat and iron infiltrates (P = 0.005 and P = 0.06), and acino-ductal metaplasia (P = 0.05) were observed compared to HFD(6) rats. MR image quantifications revealed increased elasticity, fat fraction, and R2 and a decreased elasticity wave dispersion coefficient in the high fat groups that reversed after surgery. MRI parameters were in strong correlation with respective histological counterparts. In conclusion, obese rats develop pancreatic inflammatory lesions with acinar-ductal metaplasia in acinar location and the endocrine-exocrine interface. These changes can be prevented by bariatric surgery. Quantitative MR imaging is accurate in identifying early pancreatic lesions. |
format | Online Article Text |
id | pubmed-6214994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62149942018-11-06 Obesity-induced pancreatopathy in rats is reversible after bariatric surgery Rebours, Vinciane Garteiser, Philippe Ribeiro-Parenti, Lara Cavin, Jean-Baptiste Doblas, Sabrina Pagé, Gwenaël Bado, André Couvineau, Alain Ruszniewski, Philippe Paradis, Valérie Le Gall, Maude Van Beers, Bernard E. Couvelard, Anne Sci Rep Article Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, to analyze effects of bariatric surgery. Sixty-three male Wistar rats were included in five groups: 2 fed with high fat diet (HFD) or normal diet for 3 months, 2 fed with HFD or normal diet for 6 months; 1 group fed with HFD and undergoing bariatric surgery (n = 30). Quantitative MR imaging was performed in HFD(6), ND(6) and HFD(3)-BS. Pancreas specimens were analyzed after sacrifice for adipocyte infiltration, fibrosis, acinar-ductal metaplasia, abnormality of Langerhans islets (HHF: hypertrophy, hypervascularisation, fibrosis), and hemosiderin deposits in acinar or endocrine locations. We found that HFD(6) rats had more fibro-inflammatory islets (P = 0.0139) and acinar-ducal metaplasia (P = 0.0843) than HFD(3) rats. Rats with HFD(3+6) had more fibro-inflammatory islets (P < 0.0001), hemosiderin deposits (p < 0.0001), fat infiltration (P = 0.0008) and acinar-ductal metaplasia lesions (P = 0.0424). Weight increase was associated with glycoregulation abnormalities (r = 0.44, P = 0.08) and adipocyte infiltrations (P = 0.009). After surgery, less fibro-inflammatory islets (P = 0.0004), fat and iron infiltrates (P = 0.005 and P = 0.06), and acino-ductal metaplasia (P = 0.05) were observed compared to HFD(6) rats. MR image quantifications revealed increased elasticity, fat fraction, and R2 and a decreased elasticity wave dispersion coefficient in the high fat groups that reversed after surgery. MRI parameters were in strong correlation with respective histological counterparts. In conclusion, obese rats develop pancreatic inflammatory lesions with acinar-ductal metaplasia in acinar location and the endocrine-exocrine interface. These changes can be prevented by bariatric surgery. Quantitative MR imaging is accurate in identifying early pancreatic lesions. Nature Publishing Group UK 2018-11-02 /pmc/articles/PMC6214994/ /pubmed/30390093 http://dx.doi.org/10.1038/s41598-018-34515-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rebours, Vinciane Garteiser, Philippe Ribeiro-Parenti, Lara Cavin, Jean-Baptiste Doblas, Sabrina Pagé, Gwenaël Bado, André Couvineau, Alain Ruszniewski, Philippe Paradis, Valérie Le Gall, Maude Van Beers, Bernard E. Couvelard, Anne Obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
title | Obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
title_full | Obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
title_fullStr | Obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
title_full_unstemmed | Obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
title_short | Obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
title_sort | obesity-induced pancreatopathy in rats is reversible after bariatric surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214994/ https://www.ncbi.nlm.nih.gov/pubmed/30390093 http://dx.doi.org/10.1038/s41598-018-34515-3 |
work_keys_str_mv | AT reboursvinciane obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT garteiserphilippe obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT ribeiroparentilara obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT cavinjeanbaptiste obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT doblassabrina obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT pagegwenael obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT badoandre obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT couvineaualain obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT ruszniewskiphilippe obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT paradisvalerie obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT legallmaude obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT vanbeersbernarde obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery AT couvelardanne obesityinducedpancreatopathyinratsisreversibleafterbariatricsurgery |